Riskpilot← Back to searchSign inGet full accessWatgen Medical A/S
A/SBankruptCVR 39708531Møllegade 32Manufacture of medical and dental instruments and supplies · NACE 3250Est. 20182 employees
Revenue 2021
DKK -79K
-75% vs 2020
EBITDA margin
4606.2%
-645% vs 2020
Equity ratio
98.2%
Financial strength
Net profit 2021
DKK -2,9M
-595% vs 2020
| Revenue | DKK -79K | -75% |
| EBITDA | DKK -3,6M | -645% |
| Net profit | DKK -2,9M | -595% |
| Total assets | DKK 2,5M | -73% |
| Equity | DKK 2,5M | -72% |
| Employees | 2 | — |
Legal name
Watgen Medical A/S
CVR number
39708531
Legal form
Aktieselskab
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
3. juli 2018
Share capital
DKK 483.628
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren eller af den samlede bestyrelse.
Address
Møllegade 32
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 |
|---|---|---|---|
| Revenue | -1.113 | -319 | -79 |
| Staff expenses | -481 | -170 | -94 |
| EBITDA | -1.593 | -489 | -3.645 |
| Depreciation & amort. | -7 | -7 | -7 |
| EBIT | -1.600 | -496 | -3.651 |
| Net financials | -6 | -27 | -2 |
| Profit before tax | -1.606 | -523 | -3.653 |
| Tax | -353 | -113 | -802 |
| Net profit | -1.253 | -410 | -2.851 |
| Item | 2019 | 2020 | 2021 |
|---|---|---|---|
| Total assets | 9.556 | 9.424 | 2.504 |
| Equity | 9.177 | 8.767 | 2.459 |
| Long-term debt | 38 | 0 | 0 |
| Short-term debt | 341 | 152 | 45 |
| Total debt | 378 | 152 | 45 |
EBITDA margin
-364481300.0%
This company
15.8%
Market median
-2306843771% vs market
20192021
Equity ratio
98.2%
This company
38.2%
Market median
+157% vs market
20192021
Return on equity
-115.9%
This company
18.4%
Market median
-730% vs market
20192021
Net profit margin
-285102900.0%
This company
8.1%
Market median
-3519788989% vs market
20192021
Asset turnover
-0.03×
This company
1.12×
Market median
-103% vs market
20192021
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20192021
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
TR Chief Executive Officer | Chief Executive Officer | 2018 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (5) | ||
| Chairman | 2022 – 2023 | |
| Chairman | 2018 – 2018 | |
| Board of Directors | 2018 – 2020 | |
| Board of Directors | 2019 – 2023 | |
| Chairman | 2018 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50–66.65% | 50–66.65% | 2018 | |
| Company | 10–14.99% | 10–14.99% | 2018 | |
| Company | 100% | 100% | 2022 | |
| Company | 15–19.99% | 15–19.99% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Watgen Medical A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Toke Reedtz | Chief Executive Officer | 0 companies |
| Tor Reedtz | Chairman | 0 companies |
| David Packness Meyer | Chairman | 0 companies |
| Peter Bjerring | Board of Directors | 0 companies |
| Jonathan Sorger | Board of Directors | 0 companies |
| Thomas Høgh Marschall | Chairman | 0 companies |